Skip to content

BIO FRONTIER

  • Home
  • Artificial intelligence
  • Biotechnology
  • Genetics
  • Medical Technology

Inflammation

    • Home
    • Inflammation
“ccl5/rantes:-key-to-inflammation-post-mild-tbi”
CCL5/RANTES Health Inflammation İşte içeriğe uygun 5 etiket: **mild traumatic brain injury signaling pathways therapeutic interventions** **Açıklama:** 1. **mild traumatic brain injury (mTBI):** Makalenin ana konusu ve araştırmanın temelini oluşturuyor. 2. **CCL5/RANTES:** Makalenin ve araştır

“CCL5/RANTES: Key to Inflammation Post-Mild TBI”

Jan 9, 2026

Recent studies have illuminated the intricate mechanisms of inflammation in the context of mild traumatic...

inflammation-biotech-evommune-heads-to-nyse-with-$150m-ipo
Biotechnology Inflammation Uncategorized

Inflammation biotech Evommune heads to NYSE with $150M IPO

Nov 6, 2025

Evommune is heading to the New York Stock Exchange this morning via a $150 million...

inflammation-biotech-evommune-prices-ipo-after-maplight’s-$250m-debut
Biotechnology Inflammation Uncategorized

Inflammation biotech Evommune prices IPO after MapLight’s $250M debut

Oct 30, 2025

Inflammation biotech Evommune plans to take the leap into public waters with an expected initial...

inflammation-biotech-evommune-eyes-ipo-to-fund-further-dermatitis-trials
Biotechnology Inflammation Uncategorized

Inflammation biotech Evommune eyes IPO to fund further dermatitis trials

Oct 10, 2025

Will the return of biotech IPOs become the hottest fashion trend this fall? It’s still...

  • PR Newswire
  • GlobeNewswire
  • Contact
  • Privacy Policy

BIO FRONTIER

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.